Dr. Janet Woodcock's Regulatory Address at BreakThru SCI Congressional Briefing

Former Acting Commissioner of the FDA and Former Director of CDER and CBER Dr. Janet Woodcock joins BreakThru SCI on Capitol Hill to advocate for compatible regulatory design and flexibility for innovative treatments developed for conditions like spinal cord injury.